⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9100994 | 1.00 | — | — | |
| SCHEMBL825743 | 1.00 | — | — | |
| SCHEMBL4189582 | 1.00 | — | — | |
| SCHEMBL9501980 | 1.00 | — | — | |
| SCHEMBL13947343 | 1.00 | — | — | |
| SCHEMBL10508488 | 1.00 | — | — | |
| SCHEMBL2335589 | 1.00 | — | — | |
| L-Fucose SCHEMBL3462756 | 0.91 | — | — | |
| L-Fucose SCHEMBL25051 | 0.91 | — | — | |
| L-Fucose SCHEMBL1746724 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117866025-A | Preparation method of capecitabine | 合肥亿帆生物制药有限公司 | 2024-04-12 | — | — | CN | claimed |
| CN-111377988-B | Capecitabine intermediate | 鲁南制药集团股份有限公司 | 2023-06-27 | — | — | CN | claimed |
| CN-115850356-A | Deoxynucleoside analogue and preparation method thereof | 华东理工大学 | 2023-03-28 | — | — | CN | claimed |
| CN-111377981-B | 5-deoxy-D-ribose derivative | 鲁南制药集团股份有限公司 | 2023-03-17 | — | — | CN | claimed |
| CN-109836462-B | Preparation method of triacetyl deoxyribose alpha isomer | 重庆圣华曦药业股份有限公司 | 2021-12-28 | — | — | CN | claimed |
| CN-112125939-A | Method for preparing high-purity 5-deoxy-D-ribose | 中国人民解放军陆军防化学院 | 2020-12-25 | — | — | CN | claimed |
| CN-111647028-A | Industrial large-scale production method of capecitabine intermediate | 苏州华鑫医药科技有限公司 | 2020-09-11 | — | — | CN | claimed |
| WO-2020140559-A1 | 5-DEOXY-D-RIBOSE DERIVATIVE | 山东新时代药业有限公司 | 2020-07-09 | — | — | WO | claimed |
| CN-111377988-A | Capecitabine intermediate | 山东新时代药业有限公司 | 2020-07-07 | — | — | CN | claimed |
| CN-111377981-A | 5-deoxy-D-ribose derivative | 山东新时代药业有限公司 | 2020-07-07 | — | — | CN | claimed |
| CN-109836462-A | A kind of preparation method of triacetyl deoxyribose αisomer | 重庆圣华曦药业股份有限公司 | 2019-06-04 | — | — | CN | claimed |
| CN-103910773-B | The synthetic method of capecitabine impurity | NINGBO MENOVO PHARMACEUTICAL CO., LTD. (CN) | 2015-11-25 | — | — | CN | claimed |
| CN-103910773-A | Method for synthesizing capecitabine impurities | NINGBO MENOVO PHARMACEUTICAL CO LTD | 2014-07-09 | — | — | CN | claimed |
| CN-101824056-B | Preparation method of 1,2,3-tri-O-acetyl-5-deoxidization-beta-D-ribose | JIANGSU ZHONGWEI PHARMACEUTICAL CO LTD | 2012-03-28 | — | — | CN | claimed |
| CN-101824056-A | Preparation method of 1,2,3-tri-O-acetyl-5-deoxidization-beta-D-ribose | JIANGSU ZHONGWEI PHARMACEUTICAL CO LTD | 2010-09-08 | — | — | CN | claimed |
| US-20100130734-A1 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2010-05-27 | — | — | US | claimed |
| EP-2137201-A2 | PROCESS FOR PREPARING CAPECITABINE | Dr. Reddy's Laboratories Ltd. (IN) | 2009-12-30 | — | — | EP | claimed |
| WO-2008131062-A2 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2008-10-30 | — | — | WO | claimed |
| EP-0021231-B1 | PROCESS FOR THE PREPARATION OF 5'-DEOXY-5-FLUORO URIDINE AND INTERMEDIATES IN THIS PROCESS | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1983-10-05 | — | — | EP | claimed |
| US-20260132160-A1 | IRON REPLACEMENT TREATMENTS | THE GENERAL HOSPITAL CORP (US) | 2026-05-14 | — | — | US | disclosed |
| CN-121362223-A | Preparation method of capecitabine and intermediate thereof | 南京亿华药业有限公司 | 2026-01-20 | — | — | CN | disclosed |
| US-20250388936-A1 | METHODS AND CELLS FOR THE PRODUCTION OF FLUORINATED COMPOUNDS | UNIV DANMARKS TEKNISKE (DK) | 2025-12-25 | — | — | US | disclosed |
| US-20250305028-A1 | TAGGING NUCLEIC ACIDS FOR SEQUENCE ASSEMBLY | DOVETAIL GENOMICS, LLC | 2025-10-02 | — | — | US | disclosed |
| EP-4604943-A2 | IRON REPLACEMENT TREATMENTS | The General Hospital Corporation (US) | 2025-08-27 | — | — | EP | disclosed |
| CN-120272527-A | Lasso RNA and preparation method and application thereof | 南方科技大学 | 2025-07-08 | — | — | CN | disclosed |
| CN-119855923-A | Compositions and methods for oncologic assays | 生命技术公司 | 2025-04-18 | — | — | CN | disclosed |
| US-20250011760-A1 | LIBRARY PREPARATION METHODS AND COMPOSITIONS AND USES THEREFOR | Life Technologies Corporation | 2025-01-09 | — | — | US | disclosed |
| US-12180535-B2 | Tagging nucleic acids for sequence assembly | DOVETAIL GENOMICS, LLC (US) | 2024-12-31 | — | — | US | disclosed |
| CN-119119146-A | New method for preparing 5-deoxidized triacetyl ribose | 启东东岳药业有限公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-119119146-A | New method for preparing 5-deoxidized triacetyl ribose | 启东东岳药业有限公司 | 2024-12-13 | — | — | CN | disclosed |
| US-20240376143-A1 | SELECTION INHIBITION OF DNA POLYMERASE BETA BY A COVALENT INHIBITOR | THE JOHNS HOPKINS UNIVERSITY | 2024-11-14 | — | — | US | disclosed |
| US-12065643-B2 | Library preparation methods and compositions and uses therefor | Life Technologies Corporation (US) | 2024-08-20 | — | — | US | disclosed |
| WO-2024086535-A2 | IRON REPLACEMENT TREATMENTS | THE GENERAL HOSPITAL CORPORATION (US) | 2024-04-25 | — | — | WO | disclosed |
| CN-117866025-A | Preparation method of capecitabine | 合肥亿帆生物制药有限公司 | 2024-04-12 | — | — | CN | disclosed |
| CN-117778531-A | Method for preparing molecular library, composition and application thereof | 生命技术公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117737097-A | Endonuclease VIII, and preparation method and application thereof | 广州达安基因股份有限公司 | 2024-03-22 | — | — | CN | disclosed |
| US-20240060037-A1 | MODIFIED ORGANISMS FOR ETHYLENE, ETHANE, AND METHANE BIOGENESIS AND METHODS FOR USE THEREOF | OHIO STATE INNOVATION FOUNDATION | 2024-02-22 | — | — | US | disclosed |
| CN-111108215-B | Method for preparing molecular library, composition and application thereof | 生命技术公司 | 2024-01-16 | — | — | CN | disclosed |
| WO-2023170058-A1 | METHODS AND CELLS FOR THE PRODUCTION OF FLUORINATED COMPOUNDS | DANMARKS TEKNISKE UNIVERSITET (DK) | 2023-09-14 | — | — | WO | disclosed |
| CN-219615575-U | Multifunctional ammonolysis liquid adding integrated instrument | 昆山伯利克精密仪器有限公司 | 2023-09-01 | — | — | CN | disclosed |
| EP-3957746-B1 | LIBRARY PREPARATION METHODS AND COMPOSITIONS AND USES THEREFOR | LIFE TECHNOLOGIES CORP (US) | 2023-08-23 | — | — | EP | disclosed |
| EP-4219710-A2 | TAGGING NUCLEIC ACIDS FOR SEQUENCE ASSEMBLY | Dovetail Genomics, LLC (US) | 2023-08-02 | — | — | EP | disclosed |
| CN-111377988-B | Capecitabine intermediate | 鲁南制药集团股份有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-111377988-B | Capecitabine intermediate | 鲁南制药集团股份有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-115850356-A | Deoxynucleoside analogue and preparation method thereof | 华东理工大学 | 2023-03-28 | — | — | CN | disclosed |
| CN-111377981-B | 5-deoxy-D-ribose derivative | 鲁南制药集团股份有限公司 | 2023-03-17 | — | — | CN | disclosed |
| CN-111377981-B | 5-deoxy-D-ribose derivative | 鲁南制药集团股份有限公司 | 2023-03-17 | — | — | CN | disclosed |
| CN-111377981-B | 5-deoxy-D-ribose derivative | 鲁南制药集团股份有限公司 | 2023-03-17 | — | — | CN | disclosed |
| US-11518777-B2 | Inhibitors of the shikimate pathway | EBERHARD KARLS UNIVERSITÄT TÜBINGEN (DE) | 2022-12-06 | — | — | US | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| WO-2022204489-A1 | MODIFIED ORGANISMS FOR ETHYLENE, ETHANE, AND METHANE BIOGENESIS AND METHODS FOR USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2022-09-29 | — | — | WO | disclosed |
| US-11268115-B2 | Methods for high fidelity production of long nucleic acid molecules | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2022-03-08 | — | — | US | disclosed |
| CN-109836462-B | Preparation method of triacetyl deoxyribose alpha isomer | 重庆圣华曦药业股份有限公司 | 2021-12-28 | — | — | CN | disclosed |
| CN-109836462-B | Preparation method of triacetyl deoxyribose alpha isomer | 重庆圣华曦药业股份有限公司 | 2021-12-28 | — | — | CN | disclosed |
| CN-108727440-B | Preparation method of 1,2, 3-tri-O-acetyl-5-deoxy-beta-D-ribose | 新乡拓新药业股份有限公司 | 2021-12-17 | — | — | CN | disclosed |
| CN-108484690-B | Preparation method of 1,2, 3-tri-O-acetyl-5-deoxy-beta-D-ribose | 新乡拓新药业股份有限公司 | 2021-04-30 | — | — | CN | disclosed |
| CN-107628998-B | Preparation method of lepadin alkaloid synthetic intermediate | 四川大学 | 2021-01-15 | — | — | CN | disclosed |
| CN-112125939-A | Method for preparing high-purity 5-deoxy-D-ribose | 中国人民解放军陆军防化学院 | 2020-12-25 | — | — | CN | disclosed |
| CN-112125939-A | Method for preparing high-purity 5-deoxy-D-ribose | 中国人民解放军陆军防化学院 | 2020-12-25 | — | — | CN | disclosed |
| CN-112125939-A | Method for preparing high-purity 5-deoxy-D-ribose | 中国人民解放军陆军防化学院 | 2020-12-25 | — | — | CN | disclosed |
| US-20200385416-A1 | NOVEL INHIBITORS OF THE SHIKIMATE PATHWAY | EBERHARD KARLS UNIVERSITÄT TÜBINGEN (DE) | 2020-12-10 | — | — | US | disclosed |
| EP-3713948-A2 | INHIBITORS OF THE SHIKIMATE PATHWAY AND USE OF 7-DEOXY-SEDOHEPTULOSE AS ANTIMICROBIAL AND HERBICIDAL AGENT | Eberhard Karls Universität Tübingen (DE) | 2020-09-30 | — | — | EP | disclosed |
| CN-111647028-A | Industrial large-scale production method of capecitabine intermediate | 苏州华鑫医药科技有限公司 | 2020-09-11 | — | — | CN | disclosed |
| CN-107827938-B | Preparation method of 1,2, 3-tri-O-acetyl-5-deoxy- β -D-ribose | 新乡拓新药业股份有限公司 | 2020-08-07 | — | — | CN | disclosed |
| WO-2020140559-A1 | 5-DEOXY-D-RIBOSE DERIVATIVE | 山东新时代药业有限公司 | 2020-07-09 | — | — | WO | disclosed |
| WO-2020140559-A1 | 5-DEOXY-D-RIBOSE DERIVATIVE | 山东新时代药业有限公司 | 2020-07-09 | — | — | WO | disclosed |
| CN-111377981-A | 5-deoxy-D-ribose derivative | 山东新时代药业有限公司 | 2020-07-07 | — | — | CN | disclosed |
| CN-111377988-A | Capecitabine intermediate | 山东新时代药业有限公司 | 2020-07-07 | — | — | CN | disclosed |
| CN-111377988-A | Capecitabine intermediate | 山东新时代药业有限公司 | 2020-07-07 | — | — | CN | disclosed |
| CN-111377981-A | 5-deoxy-D-ribose derivative | 山东新时代药业有限公司 | 2020-07-07 | — | — | CN | disclosed |
| CN-111377981-A | 5-deoxy-D-ribose derivative | 山东新时代药业有限公司 | 2020-07-07 | — | — | CN | disclosed |
| CN-109836462-A | A kind of preparation method of triacetyl deoxyribose αisomer | 重庆圣华曦药业股份有限公司 | 2019-06-04 | — | — | CN | disclosed |
| CN-109836462-A | A kind of preparation method of triacetyl deoxyribose αisomer | 重庆圣华曦药业股份有限公司 | 2019-06-04 | — | — | CN | disclosed |
| WO-2019101937-A2 | NOVEL INHIBITORS OF THE SHIKIMATE PATHWAY | EBERHARD KARLS UNIVERSITÄT TÜBINGEN (DE) | 2019-05-31 | — | — | WO | disclosed |
| CN-109336827-A | The preparation method of capecitabine impurity (the fluoro- 2- oxo -1,2- dihydro-pyrimidin -4- base of 5-) amyl carbamate | 山东铂源药业有限公司 | 2019-02-15 | — | — | CN | disclosed |
| CN-108727440-A | A kind of preparation method of tri--O- acetyl group -5- deoxidations-β of 1,2,3--D-ribose | 新乡拓新药业股份有限公司 | 2018-11-02 | — | — | CN | disclosed |
| CN-108558960-A | A kind of preparation method of tri--O- acetyl group -5- deoxidations-β of 1,2,3--D-ribose | 新乡拓新药业股份有限公司 | 2018-09-21 | — | — | CN | disclosed |
| CN-108484690-A | A kind of preparation method of tri--O- acetyl group -5- deoxidations-β of 1,2,3--D-ribose | 新乡拓新药业股份有限公司 | 2018-09-04 | — | — | CN | disclosed |
| CN-104404009-B | Short-chain dehydrogenase and the application of ribose and a variety of fluororiboses can be hydrolyzed | 天津科技大学 | 2018-08-28 | — | — | CN | disclosed |
| CN-107827938-A | A kind of preparation method of the deoxidation β D ribose of 1,2,3 3 O acetyl group 5 | 新乡拓新药业股份有限公司 | 2018-03-23 | — | — | CN | disclosed |
| US-20180037601-A1 | Nucleoside-Based Anti-Bacterial and Anti-Protozoan Drugs | UTI LIMITED PARTNERSHIP (CA) | 2018-02-08 | — | — | US | disclosed |
| CN-107628998-A | The preparation method of a kind of lepadin alkaloids synthetic intermediate | 四川大学 | 2018-01-26 | — | — | CN | disclosed |
| US-9523084-B2 | Phosphodeoxyribosyl transferase mutant enzymes and uses thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2016-12-20 | — | — | US | disclosed |
| WO-2016168911-A1 | NUCLEOSIDE-BASED ANTI-BACTERIAL AND ANTI-PROTOZOAN DRUGS | UTI LIMITED PARTNERSHIP (CA) | 2016-10-27 | — | — | WO | disclosed |
| CN-103910773-B | The synthetic method of capecitabine impurity | NINGBO MENOVO PHARMACEUTICAL CO., LTD. (CN) | 2015-11-25 | — | — | CN | disclosed |
| CN-104958299-A | Antifolate agent combinations in the treatment of cancer | TRACON PHARMACEUTICALS INC | 2015-10-07 | — | — | CN | disclosed |
| US-20150267181-A1 | Phosphodeoxyribosyl Transferase Mutant Enzymes and Uses Thereof | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2015-09-24 | — | — | US | disclosed |
| CN-103183713-B | The preparation method of 5-deoxy-D-ribofuranose oxygen glycosides compound | SHENYANG PHARMACEUTICAL UNIVERSITY (CN) | 2015-08-05 | — | — | CN | disclosed |
| CN-104650160-A | Novel synthesis method of capecitabine key intermediate 1,2,3-O-triacetyl-5-deoxy-D-ribose | UNIV JINAN | 2015-05-27 | — | — | CN | disclosed |
| CN-102432642-B | Synthesis method of 1,2,3-O-triacetyl-5-deoxy-D-ribofuranose | UNIV JIANGXI NORMAL SCI & TECH | 2014-07-23 | — | — | CN | disclosed |
| CN-103910773-A | Method for synthesizing capecitabine impurities | NINGBO MENOVO PHARMACEUTICAL CO LTD | 2014-07-09 | — | — | CN | disclosed |
| CN-102260298-B | Method for synthesizing 1,2,3-O-triacetyl-5-deoxy-bata-D-ribose | CHONGQING FUAN PHARMACEUTICAL GROUP CO LTD | 2014-04-09 | — | — | CN | disclosed |
| CN-103183713-A | Preparation method of 5-deoxy-D-ribofuranose oxygen glycosides compound | UNIV SHENYANG PHARMACEUTICAL | 2013-07-03 | — | — | CN | disclosed |
| CN-102140124-B | Novel synthesis process of capecitabine | HUNAN OUYA BIOLOG CO LTD | 2013-05-15 | — | — | CN | disclosed |
| EP-2516637-A1 | THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS | Plasmia Biotech, S.L. (ES) | 2012-10-31 | — | — | EP | disclosed |
| WO-2012145653-A2 | THERAPEUTIC COMBINATIONS FOR USE IN NEOPLASIA | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INC. (US) | 2012-10-26 | — | — | WO | disclosed |
| CN-102432642-A | Synthesis method of 1,2, 3-O-triacetyl-5-deoxy-D-ribofuranose | UNIV JIANGXI NORMAL SCI & TECH | 2012-05-02 | — | — | CN | disclosed |
| CN-101824056-B | Preparation method of 1,2,3-tri-O-acetyl-5-deoxidization-beta-D-ribose | JIANGSU ZHONGWEI PHARMACEUTICAL CO LTD | 2012-03-28 | — | — | CN | disclosed |
| CN-102260298-A | Method for synthesizing 1,2,3-O-triacetyl-5-deoxy-bata-D-ribose | — | 2011-11-30 | — | — | CN | disclosed |
| WO-2011104540-A1 | ONE STEP PROCESS FOR THE PREPARATION OF CAPECITABINE | GENERICS [UK] LIMITED (GB) | 2011-09-01 | — | — | WO | disclosed |
| CN-102140124-A | Novel synthesis process of capecitabine | HUNAN OUYA BIOLOG CO LTD | 2011-08-03 | — | — | CN | disclosed |
| WO-2011076894-A1 | THERMOSTABLE BIOCATALYST COMBINATION FOR NUCLEOSIDE SYNTHESIS | INSTITUT UNIV. DE CIÈNCIA I TECNOLOGIA, S.A. (ES) | 2011-06-30 | — | — | WO | disclosed |
| WO-2011067588-A1 | CYCLIC SULPHINYL ESTERS OF CYTIDINE | GENERICS [UK] LIMITED (GB) | 2011-06-09 | — | — | WO | disclosed |
| EP-2241556-A1 | METHOD FOR THE PREPARATION OF CAPECITABINE AND INTERMEDIATES USED IN SAID METHOD | Coll Farma S.L. (ES) | 2010-10-20 | — | — | EP | disclosed |
| CN-101830952-A | Preparation method of 2',3'-O-diacetyl-5'-deoxidation-5-flurocitabine | SHANGHAI COLLINS & PAULSON PHARMACEUTICALS CO LTD | 2010-09-15 | — | — | CN | disclosed |
| CN-101824056-A | Preparation method of 1,2,3-tri-O-acetyl-5-deoxidization-beta-D-ribose | JIANGSU ZHONGWEI PHARMACEUTICAL CO LTD | 2010-09-08 | — | — | CN | disclosed |
| US-20100130734-A1 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2010-05-27 | — | — | US | disclosed |
| EP-2176278-A2 | 2',3'-DI-O-ACYL-5-FLUORONUCLEOSIDES | Innovate Biotechnology S.R.L. (IT) | 2010-04-21 | — | — | EP | disclosed |
| WO-2010002454-A2 | THERAPEUTIC COMBINATIONS FOR USE IN NEOPLASIA | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC (US) | 2010-01-07 | — | — | WO | disclosed |
| EP-2137201-A2 | PROCESS FOR PREPARING CAPECITABINE | Dr. Reddy's Laboratories Ltd. (IN) | 2009-12-30 | — | — | EP | disclosed |
| WO-2008131062-A2 | PROCESS FOR PREPARING CAPECITABINE | DR. REDDY'S LABORATORIES LTD. (IN) | 2008-10-30 | — | — | WO | disclosed |
| WO-2008107771-A2 | 2',3'-DI-O-ACYL-5-FLUORONUCLEOSIDES | INNOVATE BIOTECHNOLOGY S.R.L. (IT) | 2008-09-12 | — | — | WO | disclosed |
| US-20060128956-A1 | (Purin-6-yl) amino acid and production method thereof | USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CESKE REPUBLIKY (CZ) | 2006-06-15 | — | — | US | disclosed |
| EP-1615926-A1 | (PURIN-6-YL) AMINO ACID AND PRODUCTION METHOD THEREOF | Ustav Organicke Chemie A Biochemie Akademie Ved Ceske Republiky (CZ) | 2006-01-18 | — | — | EP | disclosed |
| WO-2004094426-A1 | (PURIN-6-YL) AMINO ACID AND PRODUCTION METHOD THEREOF | USTAV ORGANICKÉ CHEMIE A BIOCHEMIE AKADEMIE VED CESKÉ REPUBLIKY (CZ) | 2004-11-04 | — | — | WO | disclosed |
| US-5360795-A | Treating cytomegalo virus and herpes simplex viruses | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1994-11-01 | — | — | US | disclosed |
| WO-1994008456-A1 | POLYSUBSTITUTED BENZIMIDAZOLES AS ANTIVIRAL AGENTS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1994-04-28 | — | — | WO | disclosed |
| WO-1994006438-A1 | ADENOSINE ANALOGUES AND METHOD OF INCREASING ADENOSINE RELEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1994-03-31 | — | — | WO | disclosed |
| US-5126361-A | Antitumor agentss | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1992-06-30 | — | — | US | disclosed |
| US-5059590-A | Antitumor agents | YAMASA SHOYU KABUSHIKI KAISHA (JP) | 1991-10-22 | — | — | US | disclosed |
| EP-0173462-B1 | ELLIPTICINE DERIVATIVE AND PRODUCTION PROCESS THEREOF | SUNTORY LIMITED (JP) | 1989-10-25 | — | — | EP | disclosed |
| EP-0331080-A2 | Imidazole derivatives, process for production thereof, and use thereof | Yamasa Shoyu Kabushiki Kaisha (JP) | 1989-09-06 | — | — | EP | disclosed |
| US-4698423-A | ANTITUMOR AGENTS | SUNTORY LIMITED (JP) | 1987-10-06 | — | — | US | disclosed |
| EP-0173462-A2 | Ellipticine derivative and production process thereof | SUNTORY LIMITED (JP) | 1986-03-05 | — | — | EP | disclosed |
| US-RE31512-E | SISOMICIN BACTERICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1984-01-31 | — | — | US | disclosed |
| EP-0021231-B1 | PROCESS FOR THE PREPARATION OF 5'-DEOXY-5-FLUORO URIDINE AND INTERMEDIATES IN THIS PROCESS | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1983-10-05 | — | — | EP | disclosed |
| EP-0007996-B1 | 4,6-DI-0-(AMINOGLYCOSYL)-1,3-DIAMINOCYCLITOLS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BAYER AG (DE) | 1983-01-26 | — | — | EP | disclosed |
| EP-0019843-B1 | SISOMICIN DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICINES | BAYER AG (DE) | 1982-09-29 | — | — | EP | disclosed |
| US-4340729-A | 5'-Deoxy-5-fluorouridine | HOFFMANN-LA ROCHE INC. (US) | 1982-07-20 | — | — | US | disclosed |
| US-4312859-A | ANTIBIOTICS, BACTERICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1982-01-26 | — | — | US | disclosed |
| EP-0021231-A2 | Process for the preparation of 5'-deoxy-5-fluoro uridine and intermediates in this process | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1981-01-07 | — | — | EP | disclosed |
| EP-0019843-A1 | Sisomicin derivatives, process for their preparation and their use as medicines | BAYER AG (DE) | 1980-12-10 | — | — | EP | disclosed |
| US-4235888-A | SISOMYCIN-TYPE ANTIBIOTICS | BAYER AKTIENGESELLSCHAFT (DE) | 1980-11-25 | — | — | US | disclosed |
| EP-0007996-A1 | 4,6-Di-0-(Aminoglycosyl)-1,3-diaminocyclitols, process for their preparation and pharmaceutical compositions containing them | BAYER AG (DE) | 1980-02-20 | — | — | EP | disclosed |
| EP-0007996-A1 | 4,6-Di-0-(Aminoglycosyl)-1,3-diaminocyclitols, process for their preparation and pharmaceutical compositions containing them | BAYER AG (DE) | 1980-02-20 | — | — | EP | disclosed |